Results 101 to 110 of about 128,118 (293)

Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2019
Acquired isolated factor VII deficiency is a rare bleeding disorder and has been reported in 31 cases. This is in contrast to congenital factor VII deficiency, which while also infrequent is the most common rare congenital bleeding disorder.
Leila Moosavi MD   +4 more
doaj   +1 more source

An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib

open access: yesIndian Journal of Medical and Paediatric Oncology, 2011
The concomitant occurrence of pregnancy and chronic myelogenous leukemia is uncommon. We describe the successful management of a 24-year-old woman in the first trimester of her pregnancy with chronic myelogenous leukemia (CML) in the chronic phase, who ...
Jovita Martin   +4 more
doaj   +1 more source

Acute Myeloid Leukemia Secondary to Radiation Therapy for Rectal Cancer: A Case Report

open access: yesCancer Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background Therapy‐related AML (t‐AML) is a subtype of acute myeloid leukemia (AML) that arises in the bone marrow and primarily affects white blood cells. It is associated with prior exposure to cytotoxic agents, including chemotherapy and radiotherapy. The risk of the disease increases with age and treatment intensity.
Ahmad Alkhaledi   +4 more
wiley   +1 more source

Permanent Sensorineural Deafness in a Patient with Chronic Myelogenous Leukemia Secondary to Intracranial Hemorrhage

open access: yesCase Reports in Hematology, 2013
A 52-year-old male presented with tinnitus and fullness in left ear for one day. Workup revealed a white blood cell count of 685×103/μL with marked increase in granulocyte series and myeloid precursors on peripheral smear.
Sakshi Kapur   +3 more
doaj   +1 more source

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors [PDF]

open access: yes, 2002
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835) point mutations, are present in approximately one third of patients with acute myeloid leukemia (AML) and have been associated with an increased relapse rate.
Bowen, D.T.   +5 more
core   +1 more source

Diffuse periostitis as the primary presenting radiological finding in an AML patient with disease relapse

open access: yesRadiology Case Reports, 2018
Acute myelogenous leukemia is a hematologic malignancy defined by the presence of myeloid blasts causing bone marrow infiltration. Evaluation and workup of acute myelogenous leukemia is based on comprehensive medical history, physical examination ...
Raza Mushtaq, MD   +3 more
doaj   +1 more source

208. Clinical outcomes of empirical versus pre-emptive broad spectrum antifungal therapy in patients with acute myelogenous leukemia receiving antimold prophylaxis [PDF]

open access: gold, 2022
Sang-Min Oh   +15 more
openalex   +1 more source

Multifactorial analysis of human blood cell responses to clinical total body irradiation [PDF]

open access: yes, 1972
Multiple regression analysis techniques are used to study the effects of therapeutic radiation exposure, number of fractions, and time on such quantal responses as tumor control and skin injury.
Lushbaugh, C. C.   +2 more
core   +1 more source

A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells

open access: yesHeliyon
The discovery of the interactome of cannabidiol (CBD), a non-psychoactive cannabinoid from Cannabis sativa L., has been here performed on chronic myelogenous leukemia cancer cells, using an optimized chemo-proteomic stage, which links Drug Affinity ...
Sara Ceccacci   +8 more
doaj   +1 more source

A patient with maculopapular rash and lichenoid skin damage caused by ponatinib

open access: yesJournal of International Medical Research, 2020
Tyrosine kinase inhibitors (TKIs) are invaluable for the treatment of patients with chronic myelogenous leukemia. Although TKIs are generally better tolerated than traditional chemotherapy, dermatologic side effects are common and present a significant ...
Ingrid Anna Teigen   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy